Article Text

Download PDFPDF

Surgical ablation of atrial fibrillation: a protocol for a systematic review and meta-analysis of randomised controlled trials
  1. Graham R McClure1,
  2. Emilie P Belley-Cote2,3,4,5,
  3. Rohit K Singal6,7,
  4. Iqbal H Jaffer8,9,
  5. Nazari Dvirnik2,4,9,
  6. Kevin R An1,
  7. Gabriel Fortin5,
  8. Jessica Spence2,10,
  9. Richard P Whitlock2,4,9
  1. 1Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada
  2. 2Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada
  3. 3Department of Medicine, McMaster University, Hamilton, Ontario, Canada
  4. 4Population Health Research Institute, Hamilton, Ontario, Canada
  5. 5Department of Medicine, Université de Sherbrooke, Sherbrooke, Quebec, Canada
  6. 6Department of Surgery, University of Manitoba, Manitoba, Ontario, Canada
  7. 7I.H. Asper Clinical Research Institute, Winnipeg, Manitoba, Canada
  8. 8Thrombosis & Atherosclerosis Research Institute (TaARI), McMaster University, Hamilton, Ontario, Canada
  9. 9Division of Cardiac Surgery, McMaster University, Hamilton, Ontario, Canada
  10. 10Department of Anesthesia, McMaster University, Hamilton, Ontario, Canada
  1. Correspondence to Dr Richard P Whitlock; Richard.Whitlock{at}phri.ca

Abstract

Introduction Atrial fibrillation (AF) affects 10% of patients undergoing cardiac surgery and is an independent risk factor for all-cause mortality, ischaemic stroke and heart failure. Surgical AF ablation has been shown to significantly improve maintenance of sinus rhythm, however, small to medium size trials conducted to date lack the power required to assess patient-important outcomes such as mortality, stroke, heart failure and health-related quality of life. Moreover, a recent randomised trial (RCT) suggested harm by surgical AF ablation with an almost threefold increase in the requirement for permanent pacemaker postablation. We aim to perform a systematic review and meta-analysis to evaluate efficacy and safety of surgical AF ablation compared to no surgical ablation.

Methods and analysis We will search Cochrane CENTRAL, MEDLINE and EMBASE for RCTs evaluating the use of surgical AF ablation, including any lesion set, versus no surgical AF ablation in adults with AF undergoing any type of cardiac surgery. Outcomes of interest include mortality, embolic events, quality of life, rehospitalisation, freedom from AF and adverse events, including need for pacemaker and worsening heart failure. Independently and in duplicate, reviewers will screen references, assess eligibility of potentially relevant studies using predefined eligibility criteria and collect data using prepiloted forms. We will pool data using a random effects model and present results as relative risk with 95% CIs for dichotomous outcomes and as mean difference with 95% CI for continuous outcomes. We will assess risk of bias using the Cochrane Collaboration tool, and quality of evidence with the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach.

Ethics and dissemination Our results will help guide clinical practice by providing the most comprehensive analysis of risks and benefits associated with the procedure. Our results will be disseminated through publication in peer-reviewed journals and conference presentations.

Trial registration number CRD42015025988.

This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors RPW, EPB-C and GRM developed the initial concept and search strategy for this work. GRM, EPB-C, RKS, IHJ, ND, KRA, GF, JS and RPW participated in the protocol design process with subject matter expertise provided. RPW, RKS, IHJ and ND contributed to cardiovascular surgery. JS contributed to statistical analysis. EBC and RW contributed to clinical epidemiology. Data abstraction forms were designed by EPB-C, GRM, RPW, IHJ, ND, KRA and GF. GRM, EPB-C, RKS, IHJ, ND, KRA, GF, JS and RPW contributed directly to the drafting of the final protocol and have reviewed and approved the final work prior to submission.

  • Funding This research has been supported through grants by the Canadian Institutes for Health Research (CIHR), the Heart and Stroke Foundation and the Mach Gaensslen Foundation.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.